These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12557231)

  • 1. Breakpoints at 1p36.3 in three MDS/AML(M4) patients with t(1;3)(p36;q21) occur in the first intron and in the 5' region of MEL1.
    Xinh PT; Tri NK; Nagao H; Nakazato H; Taketazu F; Fujisawa S; Yagasaki F; Chen YZ; Hayashi Y; Toyoda A; Hattori M; Sakaki Y; Tokunaga K; Sato Y
    Genes Chromosomes Cancer; 2003 Mar; 36(3):313-6. PubMed ID: 12557231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and laboratory study of 4 cases of myelodysplastic syndromes with t (1;3) (p36; q21)].
    Zhang MR; Liu XP; Zhang Y; Yang L; Zhou XH; Hao YS; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):99-102. PubMed ID: 16732963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEL1S, not MEL1, is overexpressed in myelodysplastic syndromes patients with t(1;3)(p36;q21).
    Xiao Z; Zhang M; Liu X; Zhang Y; Yang L; Hao Y
    Leuk Res; 2006 Mar; 30(3):332-4. PubMed ID: 16102824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of breakpoint cluster regions at 1p36.3 and 3q21 in hematologic malignancies with t(1;3)(p36;q21).
    Shimizu S; Suzukawa K; Kodera T; Nagasawa T; Abe T; Taniwaki M; Yagasaki F; Tanaka H; Fujisawa S; Johansson B; Ahlgren T; Yokota J; Morishita K
    Genes Chromosomes Cancer; 2000 Mar; 27(3):229-38. PubMed ID: 10679911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the recurrent translocation t(1;1)(p36.3;q21.1-2) in non-Hodgkin lymphoma by multicolor banding and fluorescence in situ hybridization analysis.
    Lestou VS; Ludkovski O; Connors JM; Gascoyne RD; Lam WL; Horsman DE
    Genes Chromosomes Cancer; 2003 Apr; 36(4):375-81. PubMed ID: 12619161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the breakpoints at 1p36.2 and 3p21.3 in an AML(M3) patient who had t(1;3)(p36.2;p21.3) at the third relapse.
    Tri NK; Xinh PT; Nagao H; Izumi T; Ozawa K; Toyoda A; Hattori M; Sakaki Y; Tokunaga K; Sato Y
    Genes Chromosomes Cancer; 2002 Dec; 35(4):365-7. PubMed ID: 12378531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells.
    Mochizuki N; Shimizu S; Nagasawa T; Tanaka H; Taniwaki M; Yokota J; Morishita K
    Blood; 2000 Nov; 96(9):3209-14. PubMed ID: 11050005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. t(1;3)(p36;p21) is a recurring therapy-related translocation.
    Sato Y; Izumi T; Kanamori H; Davis EM; Miura Y; Larson RA; Le Beau MM; Ozawa K; Rowley JD
    Genes Chromosomes Cancer; 2002 Jun; 34(2):186-92. PubMed ID: 11979552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies.
    Duhoux FP; Ameye G; Montano-Almendras CP; Bahloula K; Mozziconacci MJ; Laibe S; Wlodarska I; Michaux L; Talmant P; Richebourg S; Lippert E; Speleman F; Herens C; Struski S; Raynaud S; Auger N; Nadal N; Rack K; Mugneret F; Tigaud I; Lafage M; Taviaux S; Roche-Lestienne C; Latinne D; Libouton JM; Demoulin JB; Poirel HA; ;
    Br J Haematol; 2012 Jan; 156(1):76-88. PubMed ID: 22050763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conventional cytogenetics and breakpoint distribution by fluorescent in situ hybridization in patients with malignant hemopathies associated with inv(3)(q21;q26) and t(3;3)(q21;q26).
    De Braekeleer E; Douet-Guilbert N; Basinko A; Bovo C; Guéganic N; Le Bris MJ; Morel F; De Braekeleer M
    Anticancer Res; 2011 Oct; 31(10):3441-8. PubMed ID: 21965759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in normal tissues, including bone marrow, and it is not overexpressed in the t(1;3) cells.
    Lahortiga I; Agirre X; Belloni E; Vázquez I; Larrayoz MJ; Gasparini P; Lo Coco F; Pelicci PG; Calasanz MJ; Odero MD
    Oncogene; 2004 Jan; 23(1):311-6. PubMed ID: 14712237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome.
    Odero MD; Vizmanos JL; Román JP; Lahortiga I; Panizo C; Calasanz MJ; Zeleznik-Le NJ; Rowley JD; Novo FJ
    Genes Chromosomes Cancer; 2002 Sep; 35(1):11-9. PubMed ID: 12203785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangements.
    Lahortiga I; Vázquez I; Agirre X; Larrayoz MJ; Vizmanos JL; Gozzetti A; Calasanz MJ; Odero MD
    Genes Chromosomes Cancer; 2004 Jul; 40(3):179-89. PubMed ID: 15138998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rearrangements of chromosome band 1p36 in non-Hodgkin's lymphoma.
    Dave BJ; Hess MM; Pickering DL; Zaleski DH; Pfeifer AL; Weisenburger DD; Armitage JO; Sanger WG
    Clin Cancer Res; 1999 Jun; 5(6):1401-9. PubMed ID: 10389925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chromosomal structural changes in patients with myelodysplastic syndrome].
    Yu Y; Liu XP; Liu SH; Yu MH; Zhang Y; Xiao ZJ
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2693-7. PubMed ID: 18167247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of the 7q36 breakpoints in the t(7;12) involving ETV6 in infant leukemia.
    Tosi S; Hughes J; Scherer SW; Nakabayashi K; Harbott J; Haas OA; Cazzaniga G; Biondi A; Kempski H; Kearney L
    Genes Chromosomes Cancer; 2003 Oct; 38(2):191-200. PubMed ID: 12939747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low expression of MDS1-EVI1-like-1 (MEL1) and EVI1-like-1 (EL1) genes in favorable-risk acute myeloid leukemia.
    Barjesteh van Waalwijk van Doorn-Khosrovani S; Erpelinck C; Löwenberg B; Delwel R
    Exp Hematol; 2003 Nov; 31(11):1066-72. PubMed ID: 14585371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts.
    Martinelli G; Ottaviani E; Buonamici S; Isidori A; Borsaru G; Visani G; Piccaluga PP; Malagola M; Testoni N; Rondoni M; Nucifora G; Tura S; Baccarani M
    Haematologica; 2003 Nov; 88(11):1221-8. PubMed ID: 14607750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription factor GATA-2 gene is located near 3q21 breakpoints in myeloid leukemia.
    Wieser R; Volz A; Vinatzer U; Gardiner K; Jäger U; Mitterbauer M; Ziegler A; Fonatsch C
    Biochem Biophys Res Commun; 2000 Jun; 273(1):239-45. PubMed ID: 10873593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of atypical myelodysplastic syndrome with micromegakaryocytes, normal platelet count, and t(3;12)(q21;p13) with inv(3)(q21q26).
    Schnittger S; Schoch C; Streubel B; Hinrichs HF; Otremba B; Parwaresch R; Fonatsch C
    Genes Chromosomes Cancer; 1997 Nov; 20(3):292-8. PubMed ID: 9365837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.